TYLER WEST: Open Payments
NPI 1588243547 · CORNELIUS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 32 payments from 9 companies in 2025. Trend: 2023 $291 · 2024 $171 · 2025 $658
Food & beverage: $658
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $217 |
| Lilly USA, LLC | 6 | $110 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| Novo Nordisk Inc | 5 | $82 |
| AstraZeneca Pharmaceuticals LP | 3 | $66 |
| Edwards Lifesciences Corporation | 1 | $41 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Exact Sciences Corporation | 1 | $16 |
Products named: QULIPTA, MOUNJARO, TRELEGY ELLIPTA, FARXIGA, Ozempic, VRAYLAR, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), ZEPBOUND.
Industry payments across NC — which companies pay providers there.
